Literature DB >> 21882017

Serum anti-Müllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles.

Pelin Ocal1, Sezai Sahmay, Meral Cetin, Tulay Irez, Onur Guralp, Ismail Cepni.   

Abstract

OBJECTIVE: To evaluate predictive role of day-3 serum anti-Müllerian hormone (AMH) levels and antral follicle count (AFC) in ovarian hyperstimulation syndrome (OHSS) in patients undergoing IVF/ICSI cycles.
MATERIALS AND METHODS: Forty-one women with moderate/severe OHSS and 41 age matched women without OHSS were compared to evaluate the predictive value of certain risk factors for OHSS. AFC, and E(2), FSH, LH, AMH, inhibin-B levels measured on day 3 of the menstrual cycle before controlled ovarian hyperstimulation.
RESULTS: Mean FSH was significantly lower (p < 0.0001); and mean LH, AFC and AMH were significantly higher in women with OHSS compared to women without OHSS (p = 0.049, p < 0.0001 and p < 0.0001, respectively). There was no significant difference in inhibin B (p = 0.112) and estradiol (p = 0.706) between the groups. The ROC area under curve (AUC) for AMH presented the largest AUC among the listed risk factors. AMH (AUC = 0.87) and AFC (AUC = 0.74) had moderate accuracy for predicting OHSS while Inhibin B (AUC = 0.58) and LH (AUC = 0.61) had low accuracy. The cut-off value for AMH 3.3 ng/mL provided the highest sensitivity (90%) and specificity (71%) for predicting OHSS. It's positive (PPV) and negative predictive values (NPV) were 61% and 94%, respectively. The cut-off value for AFC was 8 with 78% sensitivity, 65% specificity, 52% PPV and 86% NPV.
CONCLUSION: Measurement of basal serum AMH and AFC can be used to determine the women with high risk for OHSS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21882017      PMCID: PMC3241835          DOI: 10.1007/s10815-011-9627-4

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  31 in total

Review 1.  The science behind 25 years of ovarian stimulation for in vitro fertilization.

Authors:  Nick S Macklon; Richard L Stouffer; Linda C Giudice; Bart C J M Fauser
Journal:  Endocr Rev       Date:  2006-01-24       Impact factor: 19.871

2.  Serum anti-Müllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles--implications for individualization of therapy.

Authors:  Scott M Nelson; Robin W Yates; Richard Fleming
Journal:  Hum Reprod       Date:  2007-07-18       Impact factor: 6.918

3.  Serum anti-Müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles.

Authors:  Tsung-Hsien Lee; Chung-Hsien Liu; Chuin-Chia Huang; Yi-Ling Wu; Yang-Tse Shih; Hong-Nerng Ho; Yu-Shih Yang; Maw-Shang Lee
Journal:  Hum Reprod       Date:  2007-11-13       Impact factor: 6.918

Review 4.  Polycystic ovaries and ovarian hyperstimulation syndrome: a systematic review*.

Authors:  Ian Tummon; Larisa Gavrilova-Jordan; Michael C Allemand; Donna Session
Journal:  Acta Obstet Gynecol Scand       Date:  2005-07       Impact factor: 3.636

5.  Elevated serum müllerian-inhibiting substance may be a marker for ovarian hyperstimulation syndrome in normal women undergoing in vitro fertilization.

Authors:  Gary S Nakhuda; Micheline C Chu; Jeff G Wang; Mark V Sauer; Rogerio A Lobo
Journal:  Fertil Steril       Date:  2006-03-29       Impact factor: 7.329

6.  Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study.

Authors:  Ilse A J van Rooij; Frank J M Broekmans; Gabrielle J Scheffer; Caspar W N Looman; J Dik F Habbema; Frank H de Jong; Bart J C M Fauser; Axel P N Themmen; Egbert R te Velde
Journal:  Fertil Steril       Date:  2005-04       Impact factor: 7.329

7.  Ultrasonography as a tool for the prediction of outcome in IVF patients: a comparative meta-analysis of ovarian volume and antral follicle count.

Authors:  Dave J Hendriks; Janet Kwee; Ben W J Mol; Egbert R te Velde; Frank J M Broekmans
Journal:  Fertil Steril       Date:  2007-01-18       Impact factor: 7.329

8.  Anti-Müllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology.

Authors:  A La Marca; S Giulini; A Tirelli; E Bertucci; T Marsella; S Xella; A Volpe
Journal:  Hum Reprod       Date:  2006-10-27       Impact factor: 6.918

Review 9.  Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation.

Authors:  B C J M Fauser; K Diedrich; P Devroey
Journal:  Hum Reprod Update       Date:  2007-11-15       Impact factor: 15.610

10.  Ovarian volume and antral follicle count for the prediction of low and hyper responders with in vitro fertilization.

Authors:  Janet Kwee; Mariet E Elting; Roel Schats; Joseph McDonnell; Cornelis B Lambalk
Journal:  Reprod Biol Endocrinol       Date:  2007-03-15       Impact factor: 5.211

View more
  18 in total

1.  What is the best predictor of severe ovarian hyperstimulation syndrome in IVF? A cohort study.

Authors:  Theoni B Tarlatzi; Christos A Venetis; Fabienne Devreker; Yvon Englert; Anne Delbaere
Journal:  J Assist Reprod Genet       Date:  2017-07-14       Impact factor: 3.412

2.  Antral follicle count determines poor ovarian response better than anti-Müllerian hormone but age is the only predictor for live birth in in vitro fertilization cycles.

Authors:  Mehmet Firat Mutlu; Mehmet Erdem; Ahmet Erdem; Sule Yildiz; Ilknur Mutlu; Ozgur Arisoy; Mesut Oktem
Journal:  J Assist Reprod Genet       Date:  2013-03-19       Impact factor: 3.412

3.  Attenuated AMH signaling pathway plays an important role in the pathogenesis of ovarian hyperstimulation syndrome.

Authors:  Lan Wang; Hemei Li; Jihui Ai; Jing Yue; Zhou Li; Hanwang Zhang; Yiqing Zhao
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

4.  Serum anti-müllerian hormone, follicle stimulating hormone and antral follicle count measurement cannot predict pregnancy rates in IVF/ICSI cycles.

Authors:  Sezai Sahmay; Gökhan Demirayak; Onur Guralp; Pelin Ocal; Levent M Senturk; Engin Oral; Tulay Irez
Journal:  J Assist Reprod Genet       Date:  2012-04-11       Impact factor: 3.412

5.  Risk Factors and Methods for Predicting Ovarian Hyperstimulation Syndrome (OHSS) in the in vitro Fertilization.

Authors:  S P Pakhomov; V S Orlova; I N Verzilina; N V Sukhih; A V Nagorniy; A V Matrosova
Journal:  Arch Razi Inst       Date:  2021-11-30

6.  Predictive Factors for Recovery Time in Conceived Women Suffering From Moderate to Severe Ovarian Hyperstimulation Syndrome.

Authors:  Kai Huang; Ying Shi; Gezi Chen; Hao Shi; Jun Zhai
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-15       Impact factor: 6.055

7.  An update on the prevention of ovarian hyperstimulation syndrome.

Authors:  Omar El Tokhy; Julia Kopeika; Tarek El-Toukhy
Journal:  Womens Health (Lond)       Date:  2016-08-19

8.  Diagnosis of Polycystic Ovary Syndrome: AMH in combination with clinical symptoms.

Authors:  Sezai Sahmay; Yavuz Aydin; Mahmut Oncul; Levent M Senturk
Journal:  J Assist Reprod Genet       Date:  2013-12-18       Impact factor: 3.412

Review 9.  Prevention of Ovarian Hyperstimulation Syndrome: A Review.

Authors:  Vinayak Smith; Tiki Osianlis; Beverley Vollenhoven
Journal:  Obstet Gynecol Int       Date:  2015-05-14

10.  Cut-Off Levels of Anti-Mullerian Hormone for The Prediction of Ovarian Response, In Vitro Fertilization Outcome and Ovarian Hyperstimulation Syndrome.

Authors:  Ali Salmassi; Liselotte Mettler; Jurgen Hedderich; Walter Jonat; Anupama Deenadayal; Soeren von Otte; Christel Eckmann-Scholz; Andreas Gerd Schmutzler
Journal:  Int J Fertil Steril       Date:  2015-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.